 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zelira Therapeutics Ltd. is a bio-pharmaceutical company. The firm engages in the research and development of cannabinoid-based formulations for the treatment of a variety of medical conditions. It focuses on human clinical trial program and pre-clinical research program. The company was founded by Harry Karelis, Mara Gordon, Jason Peterson, and Stewart Washer on February 18, 2003 and is headquartered in Perth, Australia.

Watchers	31
52-Wk Low	$0.55
52-Wk High	$1.65

Market Cap	$11.69M
Volume (M)	500.00
52-Wk High	$1.65
52-Wk Low	$0.55

Current Price	$0.688
Prev Close	$0.5739
Open	$0.688
Dividend Yield	0.00%
50-Day Moving Average	$0.6116
Beta	0.22
Avg. Volume	331.55
PE Ratio	-1.85

52-Week High	$1.65
52-Week Low	$0.55
Market Capitalization	$11.69M
EPS	-$0.372
Price to Book	0.37
Revenue Per Employee	N/A
Enterprise Value/EBITDA	-2.39

ZLDAF Zelira Therapeutics Limited

About

Feed

News

Fundamentals